ea0086p335 | Metabolism, Obesity and Diabetes | SFEBES2022
Sharma Nikhil
, Heer Amrita
, Symes Natalie
This study assesses adherence to the NICE guidance of GLP-1 agonist and DPP-IV inhibitor prescribing from 2021-2022, during the COVID-19 pandemic, in primary care. We took a group of 86 patients with type 2 diabetes mellitus (T2DM) and monitored HbA1c, BMI, frequency of diabetic reviews, medication changes and symptoms throughout the pandemic. Evaluation of adherence to the NICE guidance during COVID-19 and the effects on these patients was made. The intervention was an MDT me...